tiprankstipranks
Trending News
More News >
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market

Sun Pharmaceutical Industries Limited (SUNPHARMA) Ratios

Compare
3 Followers

Sun Pharmaceutical Industries Limited Ratios

IN:SUNPHARMA's free cash flow for Q4 2025 was ₹0.80. For the 2025 fiscal year, IN:SUNPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.21. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.04 2.56 2.00 2.04 1.89
Quick Ratio
1.51 1.95 1.47 1.51 1.33
Cash Ratio
0.26 0.55 0.23 0.26 0.39
Solvency Ratio
0.29 0.66 0.51 0.29 0.27
Operating Cash Flow Ratio
0.52 0.71 0.25 0.52 0.38
Short-Term Operating Cash Flow Coverage
12.82 4.27 0.80 12.82 2.15
Net Current Asset Value
₹ 184.34B₹ 250.76B₹ 184.34B₹ 162.81B₹ 122.55B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.04 0.09 0.02 0.06
Debt-to-Equity Ratio
0.03 0.05 0.12 0.03 0.08
Debt-to-Capital Ratio
0.03 0.05 0.11 0.03 0.08
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 0.00 <0.01 0.01
Financial Leverage Ratio
1.45 1.34 1.44 1.45 1.46
Debt Service Coverage Ratio
6.79 4.02 1.76 6.79 1.49
Interest Coverage Ratio
63.97 43.90 54.10 63.97 45.56
Debt to Market Cap
<0.01 <0.01 0.03 <0.01 0.02
Interest Debt Per Share
5.91 14.64 29.43 5.91 16.71
Net Debt to EBITDA
0.19 -0.43 0.19 -0.48 -0.48
Profitability Margins
Gross Profit Margin
69.53%48.05%75.36%69.53%70.17%
EBIT Margin
11.99%23.62%22.08%11.99%8.87%
EBITDA Margin
17.44%28.97%27.92%17.44%15.08%
Operating Profit Margin
21.20%21.92%21.50%21.20%19.40%
Pretax Profit Margin
11.66%23.22%21.74%11.66%8.45%
Net Profit Margin
8.52%20.05%19.58%8.52%8.76%
Continuous Operations Profit Margin
8.82%20.12%19.67%8.82%6.86%
Net Income Per EBT
73.03%86.37%90.06%73.03%103.73%
EBT Per EBIT
55.00%105.92%101.11%55.00%43.55%
Return on Assets (ROA)
10.49%11.21%10.49%4.69%4.29%
Return on Equity (ROE)
15.13%15.04%15.13%6.82%6.25%
Return on Capital Employed (ROCE)
15.29%15.29%15.29%15.49%12.48%
Return on Invested Capital (ROIC)
12.61%12.75%12.61%11.59%9.63%
Return on Tangible Assets
13.51%14.04%13.51%5.72%5.21%
Earnings Yield
3.59%2.45%3.59%1.49%2.02%
Efficiency Ratios
Receivables Turnover
3.47 4.24 3.78 3.47 3.64
Payables Turnover
2.61 4.39 1.88 2.61 2.49
Inventory Turnover
1.30 2.41 1.01 1.30 1.10
Fixed Asset Turnover
3.44 4.23 3.81 3.44 2.97
Asset Turnover
0.55 0.56 0.54 0.55 0.49
Working Capital Turnover Ratio
2.39 2.06 2.29 2.39 2.19
Cash Conversion Cycle
262.02 154.34 262.02 246.03 285.68
Days of Sales Outstanding
96.62 86.06 96.62 105.19 100.21
Days of Inventory Outstanding
359.90 151.44 359.90 280.49 332.20
Days of Payables Outstanding
194.50 83.16 194.50 139.65 146.72
Operating Cycle
456.52 237.50 456.52 385.68 432.40
Cash Flow Ratios
Operating Cash Flow Per Share
37.45 50.58 20.67 37.45 25.72
Free Cash Flow Per Share
31.21 41.40 11.98 31.21 20.84
CapEx Per Share
6.23 9.18 8.69 6.23 4.88
Free Cash Flow to Operating Cash Flow
0.83 0.82 0.58 0.83 0.81
Dividend Paid and CapEx Coverage Ratio
2.46 2.38 1.08 2.46 2.26
Capital Expenditure Coverage Ratio
6.01 5.51 2.38 6.01 5.27
Operating Cash Flow Coverage Ratio
6.96 3.71 0.72 6.96 1.59
Operating Cash Flow to Sales Ratio
0.23 0.25 0.11 0.23 0.19
Free Cash Flow Yield
1.22%2.54%1.22%3.41%3.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
67.06 40.82 27.84 67.06 49.39
Price-to-Sales (P/S) Ratio
5.71 8.19 5.45 5.71 4.33
Price-to-Book (P/B) Ratio
4.57 6.14 4.21 4.57 3.09
Price-to-Free Cash Flow (P/FCF) Ratio
29.30 39.35 82.08 29.30 28.69
Price-to-Operating Cash Flow Ratio
24.43 32.21 47.56 24.43 23.25
Price-to-Earnings Growth (PEG) Ratio
5.27 3.14 0.18 5.27 -2.16
Price-to-Fair Value
4.57 6.14 4.21 4.57 3.09
Enterprise Value Multiple
32.28 27.82 19.71 32.28 28.21
Enterprise Value
2.38T 3.85T 2.38T 2.16T 1.41T
EV to EBITDA
19.71 27.82 19.71 32.28 28.21
EV to Sales
5.50 8.06 5.50 5.63 4.26
EV to Free Cash Flow
82.87 38.75 82.87 28.88 28.20
EV to Operating Cash Flow
48.02 31.72 48.02 24.07 22.86
Tangible Book Value Per Share
160.41 207.73 172.03 160.41 156.42
Shareholders’ Equity Per Share
200.10 265.35 233.38 200.10 193.65
Tax and Other Ratios
Effective Tax Rate
0.24 0.13 0.09 0.24 0.18
Revenue Per Share
160.15 199.05 180.38 160.15 138.12
Net Income Per Share
13.64 39.91 35.32 13.64 12.10
Tax Burden
0.90 0.86 0.90 0.73 1.04
Interest Burden
0.98 0.98 0.98 0.97 0.95
Research & Development to Revenue
0.05 0.07 0.05 0.06 0.06
SG&A to Revenue
0.07 0.07 0.07 0.06 0.07
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.53 1.27 0.53 2.00 2.20
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis